Condensed Statement of Shareholders' Deficiency (Unaudited) - USD ($)	3 Months Ended	9 Months Ended
	Oct. 31, 2018	Oct. 31, 2018
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Balances - February 1, 2018		$ (569,705)
Net loss	$ (18,384)	(58,919)
Balances - April 30, 2018	$ (628,624)	$ (628,624)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Balances - February 1, 2018 (in shares)		1,899,575
Balances - February 1, 2018		$ 1,900
Balances - April 30, 2018 (in shares)	1,899,575	1,899,575
Balances - April 30, 2018	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Balances - February 1, 2018		8,418,684
Balances - April 30, 2018	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Balances - February 1, 2018		(8,990,289)
Net loss		(58,919)
Balances - April 30, 2018	$ (9,049,208)	$ (9,049,208)